SIS
ONCY

Sound Income Strategies’s Oncolytics Biotech ONCY Stock Holding History

Sound Income Strategies’s Portfolio ONCY Stock Details ONCY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-194
Closed -$180 – 1785
2026
Q1 		$180 Hold
194
– – ﹤0.01% 2477
2025
Q4 		$196 Hold
194
– – ﹤0.01% 2433
2025
Q3 		$241 Hold
194
– – ﹤0.01% 1593
2025
Q2 		$150 Hold
194
– – ﹤0.01% 1533
2025
Q1 		$107 Buy
+194
New +$142 ﹤0.01% 1496

Other funds holding ONCY

IAIM
International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return
EFG
Everhart Financial Group Dublin, Ohio $1.56B AUM 34.29% 1-Year Est. Return
PI
PFG Investments Woodbury, New York $2.58B AUM 36.93% 1-Year Est. Return
DA
Doliver Advisors Houston, Texas $442M AUM 34.09% 1-Year Est. Return
Fifth Third Bancorp
Fifth Third Bancorp Cincinnati, Ohio $61.7B AUM 33.76% 1-Year Est. Return
BPWM
Badgley Phelps Wealth Managers Seattle, Washington $5.71B AUM 30.33% 1-Year Est. Return
CA
Clearstead Advisors Cleveland, Ohio $10.6B AUM 24.87% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
PAS
Professional Advisory Services Vero Beach, Florida $836M AUM 25.79% 1-Year Est. Return

Sound Income Strategies's ONCY Position: Q2 2026 in Review

Sound Income Strategies sold out of Oncolytics Biotech (ONCY) in Q2 2026, closing a stake of 194 shares — an estimated $180 sold.

Sound Income Strategies first reported a position in ONCY in Q1 2025 and held it in 5 quarters. The position peaked at $241 in Q3 2025. 28 funds tracked by Wall St. Rank hold ONCY as of Q2 2026.

  • Sound Income Strategies reported no remaining Oncolytics Biotech position as of Q2 2026 after selling out during the quarter.
  • Sound Income Strategies sold 194 Oncolytics Biotech shares in Q2 2026, an estimated $180.
  • Sound Income Strategies first reported a position in Oncolytics Biotech in Q1 2025 and held it in 5 quarters.
  • Sound Income Strategies's Oncolytics Biotech position peaked at $241 in Q3 2025.
  • 28 funds tracked by Wall St. Rank held Oncolytics Biotech as of Q2 2026.

Based on Sound Income Strategies's 13F filing for Q2 2026, filed 20 Jul 2026.